Coffea ugandae

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• Alzheimer dementia [Insufficient Evidence]
• diabetes [Insufficient Evidence]
• HTN [Insufficient Evidence]
• hypercholesterolemia [Insufficient Evidence]
• metabolic syndrome [Insufficient Evidence]
• obesity [Possibly Effective]

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies w/ variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

HTN

[Insufficient Evidence]

Dose: 50-140 mg chlorogenic acids PO qd; Info: stdzd extracts typically contain 30.9-54% chlorogenic acids

hypercholesterolemia

[Insufficient Evidence]

Dose: 700 mg PO tid

metabolic syndrome

[Insufficient Evidence]

Dose: 400 mg PO bid

obesity

[Possibly Effective]

Dose: 90-1000 mg PO qd